Farid Kehdy, MD
Surgery · Louisville, KYNPI 1407966138
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. TELA Bio, Inc. accounts for 81.8% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $14,657 and has fallen 84.5% since, to $2,273 in 2025. Among surgery clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 122 payments — averaging $176.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TELA Bio, Inc.$18K
- Intuitive Surgical$2K
- AbbVie$605
- Medtronic$286
- Johnson & Johnson$179
- Acera Surgical, Inc.$98
- plus $472 from 13 others
Across 3 payments — averaging $19,718 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$33K
- TELA Bio, Inc.$27K
What the payments were for
- Consulting fees$12,90060%
- Travel & lodging$3,45516%
- Food & beverage$4,12519%
- Education$1,0825%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TELA Bio, Inc. | 46 | $17,639 |
| Intuitive Surgical | 22 | $2,282 |
| AbbVie(2 entities) | 20 | $605 |
| Medtronic | 3 | $286 |
| Johnson & Johnson | 5 | $179 |
| Acera Surgical, Inc. | 1 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $98 |
| RTI Surgical, Inc | 2 | $72 |
| Shire North American Group Inc | 5 | $68 |
| Covidien LP | 1 | $50 |
| Cerus Corporation | 2 | $40 |
| Davol Inc. | 1 | $27 |
| Medical Device Business Services, Inc. | 2 | $25 |
| KCI USA, Inc. | 1 | $17 |
| Integra Lifesciences Corporation | 1 | $16 |
| Polarityte, Inc. | 1 | $16 |
| Acacia Pharma Inc | 1 | $15 |
| Lucid Diagnostics Inc. | 1 | $14 |
| Smith+Nephew | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$21,562 in reported general payments places this provider in the 90th percentile of 377 surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Esomeprazole Magnesium | 13 | $646 |
| Pantoprazole Sodium | 39 | $333 |
| Ondansetron Hcl | 14 | $115 |
| Metoclopramide Hcl | 11 | $60 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $47 |
Paid to pharmacies, not to this prescriber.
Other surgery in Louisville
- John OldhamLouisville$515K
- Frank MillerLouisville$119K
- Jared DavisLouisville$89K
- Timothy DawsonLouisville$63K
- Gary VitaleLouisville$63K
- John OlsofkaLouisville$42K
- Keith MillerLouisville$38K
- Gerald CheadleLouisville$22K
- George MarshallLouisville$19K
- Bradley SchwackLouisville$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.